{"disease":{"id":"vitreomacular-traction-syndrome","name":"Vitreomacular traction syndrome","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"ocriplasmin","indication_name":"Vitreomacular traction syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jetrea","generic_name":"OCRIPLASMIN","company_name":"Thrombogenics, Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Proteolytic Enzyme","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"microplasmin","indication_name":"Vitreomacular traction syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Microplasmin","company_name":"University of California, Los Angeles","drug_phase":"discontinued","molecular_target":"","drug_class":"","quality_score":null,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03945695","title":"Pneumovitreolysis for Vitreomacular Traction","phase":"NA","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"University of Split, School of Medicine","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}